About
Technology
Issues
FAQ
Links
Official Page
Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.